New Paragraph IV Certifications as of April 17, 2018
DRUG NAME | DOSAGE FORM | STRENGTH | RLD | DATE OF SUBMISSION |
---|---|---|---|---|
Axitinib | Tablets | 1 mg and 5 mg | Inlyta, 202324 | 2/23/2018 |
Betamethasone Dipropionate | Topical Spray | 0.05% | Sernivo, 208079 | 2/15/2018 |
Morphine Sulfate | Extended-release Tablets | 15 mg, 30 mg and 60 mg | Arymo ER, 208603 | 12/29/2017 |
Click here to view full list of Paragraph IV Certificates filed as of April 17, 2018
No comments